Integra Lifesciences Holdings Corp
關鍵數據
17.150今開
17.590最高
935.09K成交量
虧損本益比TTM
6.35本益比動
--股利TTM
1.20%換手率
17.120昨收
16.240最低
11.95M成交額
虧損本益比靜
1.24市淨率
0.00%股息率 TTM
-13.00%ROA
16.62052週最高
0.63量比
-6.94M淨利潤
77.89M總股本
-6.4654每股盈餘TTM
1.23Beta
-38.64%ROE
8.70052週最低
7.89%振幅
54.90%毛利率
1.29B總市值
-1.70回報/風險
3.43%風險率
操作建議
Integra Lifesciences Holdings Corp當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名65/199位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為20.00。中期看,股價處於上升通道。近一個月,市場表現較差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Integra Lifesciences Holdings Corp評分
壓力支撐

由於公司未披露,未能獲取相關數據
Integra Lifesciences Holdings Corp亮點
亮點風險
Integra Lifesciences Holdings Corp新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Integra Lifesciences Holdings Corp
IART
12
Zimmer Biomet Holdings Inc
ZBH
31
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
Integra Lifesciences Holdings Corp簡介
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
公司代碼IART
公司Integra Lifesciences Holdings Corp
CEOPoul (Mojdeh)
網址https://www.integralife.com/
公司股東
常見問題
Integra Lifesciences Holdings Corp(IART)的當前股價是多少?
Integra Lifesciences Holdings Corp(IART)的當前股價是 16.65。
Integra Lifesciences Holdings Corp 的股票代碼是什麼?
Integra Lifesciences Holdings Corp的股票代碼是IART。
Integra Lifesciences Holdings Corp股票的52週最高點是多少?
Integra Lifesciences Holdings Corp股票的52週最高點是16.62。
Integra Lifesciences Holdings Corp股票的52週最低點是多少?
Integra Lifesciences Holdings Corp股票的52週最低點是8.70。
Integra Lifesciences Holdings Corp的市值是多少?
Integra Lifesciences Holdings Corp的市值是1.29B。
現在Integra Lifesciences Holdings Corp(IART)的股票是買入、持有還是賣出?
根據分析師評級,Integra Lifesciences Holdings Corp(IART)的總體評級為signal_hold,目標價格為20.00。
Integra Lifesciences Holdings Corp(IART)股票的每股收益(EPS TTM)是多少
Integra Lifesciences Holdings Corp(IART)股票的每股收益(EPS TTM)是-6.74。